SCFA-mediated FFAR2/3 signaling plays crucial roles in glucose and lipid metabolic pathways [142], and a few studies showcasing perturbed FFAR2 expression in mice underscore the important association between SCFA and cardiometabolic risk in models of obesity. Here, FFAR2 is linked to obesity due to melanocortin 4 receptor deficiency.